Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2 | P10415 | 7/20 | 0.65 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.62 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.62 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.62 |
| ▸ | BCL2L2 | Q92843 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1958733 | 0.91 | BCL2 (0.79) | BCL2BCL2L1MCL1TMEM97BCL2L2 | |
| SCHEMBL3513752 | 0.91 | BCL2 (0.79) | BCL2BCL2L1MCL1TMEM97BCL2L2 | |
| SCHEMBL1957412 | 0.85 | BCL2 (0.85) | BCL2 | |
| SCHEMBL19424509 | 0.85 | BCL2 (0.69) | BCL2BCL2L1MCL1TMEM97BCL2L2 | |
| SCHEMBL1954857 | 0.82 | BCL2 (0.78) | BCL2BCL2L1MCL1TMEM97BCL2L2 | |
| SCHEMBL1954859 | 0.82 | BCL2 (0.78) | BCL2BCL2L1MCL1TMEM97BCL2L2 | |
| SCHEMBL1955310 | 0.82 | BCL2 (0.78) | BCL2BCL2L1MCL1TMEM97BCL2L2 | |
| SCHEMBL1955306 | 0.82 | BCL2 (0.78) | BCL2BCL2L1MCL1TMEM97BCL2L2 | |
| SCHEMBL1957271 | 0.81 | BCL2 (0.64) | BCL2 | |
| SCHEMBL1959144 | 0.81 | BCL2 (0.74) | BCL2BCL2L1MCL1TMEM97BCL2L2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2642999-A1 | METHODS OF TREATMENT USING SELECTIVE BCL-2 INHIBITORS | AbbVie Inc. (US) | 2013-10-02 | — | — | EP | disclosed |
| WO-2012071374-A1 | METHODS OF TREATMENT USING SELECTIVE BCL-2 INHIBITORS | ABBOTT LABORATORIES (US) | 2012-05-31 | — | — | WO | disclosed |